| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical Trials Report
|
Siragy, Helmy M.
|
|
2003
|
5 |
4 |
p. 293-294
|
artikel
|
| 2 |
Clinical Trials Report
|
Weber, Michael A.
|
|
2003
|
5 |
4 |
p. 319-321
|
artikel
|
| 3 |
Has the role of calcium channel blockers in treating hypertension finally been defined?
|
Chrysant, George S.
|
|
2003
|
5 |
4 |
p. 295-300
|
artikel
|
| 4 |
Lessons from trials in hypertensive type 2 diabetic patients
|
Ruilope, Luis M.
|
|
2003
|
5 |
4 |
p. 322-328
|
artikel
|
| 5 |
Literature alert
|
|
|
2003
|
5 |
4 |
p. 284-289
|
artikel
|
| 6 |
Management of diabetic and hypertensive cardiovascular disease
|
Frohlich, Edward D.
|
|
2003
|
5 |
4 |
p. 309-315
|
artikel
|
| 7 |
Ongoing trials: What should we expect after ALLHAT?
|
Wang, Ji-Guang
|
|
2003
|
5 |
4 |
p. 340-345
|
artikel
|
| 8 |
Recent clinical trials with omapatrilat: New developments
|
Zanchi, Anne
|
|
2003
|
5 |
4 |
p. 346-352
|
artikel
|
| 9 |
Regression of left ventricular hypertrophy is a key goal of hypertension management
|
Zhang, Rubin
|
|
2003
|
5 |
4 |
p. 301-308
|
artikel
|
| 10 |
Renal handling of angiotensin receptor blockers: Clinical relevance
|
Sica, Domenic A.
|
|
2003
|
5 |
4 |
p. 337-339
|
artikel
|
| 11 |
Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: Rationale and options
|
Grassi, Guido
|
|
2003
|
5 |
4 |
p. 277-280
|
artikel
|
| 12 |
Trials in isolated systolic hypertension: An update
|
Waeber, Bernard
|
|
2003
|
5 |
4 |
p. 329-336
|
artikel
|
| 13 |
Web alert
|
|
|
2003
|
5 |
4 |
p. 281-283
|
artikel
|
Tijdschrift beschrijving